Literature DB >> 16721637

Validation of a specific questionnaire on psychological and social repercussions of the lipodystrophy syndrome in HIV-infected patients.

Ana Marín1, José L Casado, Lidia Aranzabal, Javier Moya, Antonio Antela, Fernando Dronda, Ana Moreno, Santiago Moreno.   

Abstract

OBJECTIVE: To validate a questionnaire to identify psychosocial repercussions of the lipodystrophy syndrome (LD) in HIV-infected patients.
METHODS: A questionnaire containing 35 items in 6 subscales [body image, anxiety, depression, social support, social distress, quality of life (QoL)] was consecutively administered to 128 patients with LD, 25 naive patients or on therapy without LD, and to 15 HIV negative patients from January to July '04. Reliability was assessed using Cronbach's alpha and the intraclass correlation coefficient (ICC). The area under the curve (AUC) was used for discrimination between patients and control groups, and the scores were compared according to the severity of the LD.
RESULTS: In all the subscales, the relationship between higher scores and LD severity was statistically significant (0.37-0.64, p<0.01), whereas the control groups had significantly lower scores. The internal consistency showed Cronbach's alpha coefficients ranging from 0.64 to 0.93. Test-retest reliability after 15 days in 30 patients showed ICC values of 0.8-0.94. AUC values for the different subscales were higher than 0.7 with the exception of QoL score, and construct validity showed a significant correlation with the Beck Depression Inventory and the MOS-HIV scores (0.49 and 0.51, respectively, p<0.01).
CONCLUSIONS: Our questionnaire shows satisfactory psychometric properties for identifying psychosocial repercussions of the LD in HIV-infected patients.

Entities:  

Mesh:

Year:  2006        PMID: 16721637     DOI: 10.1007/s11136-005-5001-2

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   3.440


  16 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

2.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

3.  Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness.

Authors:  S Swindells; J Mohr; J C Justis; S Berman; C Squier; M M Wagener; N Singh
Journal:  Int J STD AIDS       Date:  1999-06       Impact factor: 1.359

4.  Psychosocial impact of the lipodystrophy syndrome in HIV infection.

Authors:  E Collins; C Wagner; S Walmsley
Journal:  AIDS Read       Date:  2000-09

5.  Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study.

Authors:  Hernando Knobel; Jordi Alonso; José L Casado; Julio Collazos; Juan González; Isabel Ruiz; José M Kindelan; Alexia Carmona; Javier Juega; Antonio Ocampo
Journal:  AIDS       Date:  2002-03-08       Impact factor: 4.177

Review 6.  Lipodystrophy syndrome in patients with HIV infection: quality of life issues.

Authors:  E Martínez; M A Garcia-Viejo; L Blanch; J M Gatell
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

7.  A comparison of Likert scale and visual analogue scales as response options in children's questionnaires.

Authors:  H van Laerhoven; H J van der Zaag-Loonen; B H F Derkx
Journal:  Acta Paediatr       Date:  2004-06       Impact factor: 2.299

8.  A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals.

Authors:  R Power; H L Tate; S M McGill; C Taylor
Journal:  Sex Transm Infect       Date:  2003-04       Impact factor: 3.519

9.  Change in clinical status, health status, and health utility outcomes in HIV-infected patients.

Authors:  D A Revicki; A W Wu; M I Murray
Journal:  Med Care       Date:  1995-04       Impact factor: 2.983

10.  A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection.

Authors:  A W Wu; H R Rubin; W C Mathews; J E Ware; L T Brysk; W D Hardy; S A Bozzette; S A Spector; D D Richman
Journal:  Med Care       Date:  1991-08       Impact factor: 2.983

View more
  12 in total

Review 1.  Considering metabolic issues when initiating HIV therapy.

Authors:  David Alain Wohl
Journal:  Curr HIV/AIDS Rep       Date:  2007-08       Impact factor: 5.071

2.  Depression longitudinally mediates the association of appearance concerns to ART non-adherence in HIV-infected individuals with a history of injection drug use.

Authors:  Aaron J Blashill; Janna R Gordon; Steven A Safren
Journal:  J Behav Med       Date:  2012-11-22

Review 3.  A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trials.

Authors:  Darren J Clayson; Diane J Wild; Paul Quarterman; Isabelle Duprat-Lomon; Maria Kubin; Stephen Joel Coons
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  Assessing appearance-related disturbances in HIV-infected men who have sex with men (MSM): psychometrics of the body change and distress questionnaire-short form (ABCD-SF).

Authors:  Aaron J Blashill; Johannes M Wilson; Joshua S Baker; Kenneth H Mayer; Steven A Safren
Journal:  AIDS Behav       Date:  2014-06

5.  Severity of lipodystrophy is associated with decreased health-related quality of life.

Authors:  Giovanni Guaraldi; Rita Murri; Gabriella Orlando; Chiara Giovanardi; Nicola Squillace; Marcella Vandelli; Barbara Beghetto; Giulia Nardini; Maria De Paola; Roberto Esposito; Albert W Wu
Journal:  AIDS Patient Care STDS       Date:  2008-07       Impact factor: 5.078

6.  Lipoatrophy among HIV-infected patients is associated with higher levels of depression than lipohypertrophy.

Authors:  H M Crane; C Grunfeld; R D Harrington; K K Uldall; P S Ciechanowski; M M Kitahata
Journal:  HIV Med       Date:  2008-08-27       Impact factor: 3.180

7.  Appearance concerns and psychological distress among HIV-infected individuals with injection drug use histories: prospective analyses.

Authors:  Aaron J Blashill; Janna R Gordon; Steven A Safren
Journal:  AIDS Patient Care STDS       Date:  2012-07-13       Impact factor: 5.078

8.  Quality of life of people living with HIV and AIDS and antiretroviral therapy.

Authors:  Oluwafemi O Oguntibeju
Journal:  HIV AIDS (Auckl)       Date:  2012-08-06

9.  Lipodystrophy in HIV patients: its challenges and management approaches.

Authors:  Rohit Singhania; Donald P Kotler
Journal:  HIV AIDS (Auckl)       Date:  2011-12-14

10.  New and emerging agents in the management of lipodystrophy in HIV-infected patients.

Authors:  Eric Bonnet
Journal:  HIV AIDS (Auckl)       Date:  2010-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.